Evidence map›Paper›PMID 29069713›Full record

ArticleOncotarget2017

Selective DNA methylation in cancers controls collateral damage induced by large structural variations.

Vakul Mohanty, Ogulsheker Akmamedova, Kakajan Komurov

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Context is everything: aneuploidy in cancer.Nature reviews. Genetics · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Vakul MohantySystems Biology and Physiology Graduate Program, University of Cincinnati, OH, USA.
Ogulsheker AkmamedovaGraduate program in Mathematics, Fatih University, Istanbul, Turkey.
Kakajan KomurovDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, OH, USA.
Cincinnati Children's Hospital Medical Center · USFatih University · TRUniversity of Cincinnati · US

Funding

Exploiting proteotoxic stress in therapy-refractory HER2+ breast cancersR01CA193549 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI PRIVETTE VINNEDGE, LISA M. · 2015 to 2019
$1.8M
NCI NIH HHS R01 CA193549
6 · The paper itself

Abstract

Chromosomal instability is a hallmark of human cancers, and is characterized by large structural variations in the genome. Such large structural variations are expected to create intrinsic collateral stress due to gene dosage changes in many genes that are co-deleted or co-amplified in large chromosomal segments (

Indexed as

computational cancer biologyTCGA

Identifiers

PMID29069713
PMCPMC5641056
OpenAlexW2461885937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.